JPRN-UMIN000033725已完成未知
Therapeutic effect on disodium pamidronate administration to diffuse sclerosing mandible osteomyelitis - On the effect of disodium pamidronate on diffuse curable mandibular osteomyelitis
Department of Oral and Maxillofacial Surgery, Osaka Medical and Pharmaceutical University0 个研究点目标入组 5 人开始时间: 2020年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who did not obtain consent to this study
研究者
相似试验
已完成
不适用
Pamidronate and disease activity in rheumatoid arthritisRheumatoid arthritis.Seropositive rheumatoid arthritisIRCT138801051778N1Vice chancellery of research37
已完成
2 期
Treatment of thalassemia-induced osteoporosis with pamidronateThalassemia.Beta thalassemiaD56.1IRCT20211008052698N1Oroumia University of Medical Sciences20
已完成
不适用
Study Into the Effect of Pamidronate for the Prevention of Heterotopic Ossification in High-Risk Patients: A Randomized Controlled TrialEstablished heterotopic ossificationMusculoskeletal DiseasesHeterotopic ossificationISRCTN01332857niversity Hospital of Basel (Switzerland)40
已完成
不适用
comparison of Pamidronate and calcium-D effect on bone mineral density of renal transplant patients in IsfahaEnd Stage Renal Disease.End-stage renal diseaseIRCT138903252417N2Isfahan University of Medical Sciences34
已完成
不适用
Efficacy and safety of minodronate in the treatment of glucocorticoid-induced osteoporosisJPRN-UMIN000011896Department of Medicine, School of Medicine, Nihon University30